Joe.My.God. LGBT News
NBC News reports:
Additional data from Pfizer’s clinical trial of its oral Covid-19 antiviral drug confirm the treatment’s high level of effectiveness, the company said in a news release Tuesday.
In the final analysis of its Phase 2/3 clinical trial, the antiviral, called Paxlovid, was found to be 89 percent effective at preventing high-risk people from being hospitalized or dying from Covid, the company said.
Experts say an antiviral pill for Covid would have a major impact on the pandemic by making treatment available at home. Current treatments are available only by injection or IV.
Read the full article.
Pfizer’s final results for its experimental Covid-19 pill showed it cut the risk of hospitalization or death for some by 89%, the company says https://t.co/c3so1TBB8P
— CNN Breaking News (@cnnbrk) December 14, 2021